Concepedia

Michael Teifel

MT

Statistics

Publications

17

Citations

1.3K

H-Index

15

Active since

1996

Affiliations

LMU Klinikum(Current)

Aeterna Zentaris (Germany)

München Klinik

Darmstadt University of Applied Sciences

Ludwig-Maximilians-Universität München

Michael Teifel is an author at LMU Klinikum specializing in pharmacology, drug delivery, and cationic liposomes.

ORCID

Publications per year

1996–2021

17

Publications

17

Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels

Senat Krasnici, Alexander Werner, Martin Eichhorn et al. · International Journal of Cancer · 2003 · 313 citations · Full text

, , +17

Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy.

M. Schmitt‐Sody, Sebastian Strieth, Senat Krasnici et al. · PubMed · 2003 · 196 citations

, , +17

Paclitaxel Encapsulated in Cationic Liposomes Diminishes Tumor Angiogenesis and Melanoma Growth in a “Humanized” SCID Mouse Model

Rainer Kunstfeld, Georg Wickenhauser, Uwe Michaelis et al. · Journal of Investigative Dermatology · 2003 · 143 citations · Full text

, , +16

Immortalization of human corneal endothelial cells using electroporation protocol optimized for human corneal endothelial and human retinal pigment epithelial cells

J. Bednarz, Michael Teifel, Peter Friedl et al. · Acta Ophthalmologica Scandinavica · 2000 · 123 citations

, , +9

Neovascular targeting chemotherapy: Encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature

Sebastian Strieth, Martin Eichhorn, Birgitta Sauer et al. · International Journal of Cancer · 2004 · 105 citations · Full text

, , +17

1–5 of 17